Market Value2,994,349,040
Total Holdings60
File Date2024-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
PNT / POINT Biopharma Global Inc.
GHRS / GH Research PLC
ABVX / ABIVAX Société Anonyme - Depositary Receipt (Common Stock)
ATXS / Astria Therapeutics, Inc.
CYTK / Cytokinetics, Incorporated
INSM / Insmed Incorporated
AMLX / Amylyx Pharmaceuticals, Inc.
BEAM / Beam Therapeutics Inc.
IMVT / Immunovant, Inc.
ABOS / Acumen Pharmaceuticals, Inc.
RAPT / RAPT Therapeutics, Inc.
AGIO / Agios Pharmaceuticals, Inc.
JAZZ / Jazz Pharmaceuticals plc
GERN / Geron Corporation
OCUL / Ocular Therapeutix, Inc.
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
ZURA / Zura Bio Limited
NRIX / Nurix Therapeutics, Inc.
IONS / Ionis Pharmaceuticals, Inc.
RPTX / Repare Therapeutics Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
NKTR / Nektar Therapeutics
MORF / Morphic Holding, Inc.
PLRX / Pliant Therapeutics, Inc.
ANIP / ANI Pharmaceuticals, Inc.
AXSM / Axsome Therapeutics, Inc.
TERN / Terns Pharmaceuticals, Inc.
SRRK / Scholar Rock Holding Corporation
SLN / Silence Therapeutics plc - Depositary Receipt (Common Stock)
ETNB / 89bio, Inc.
SYRS / Syros Pharmaceuticals, Inc.
APGE / Apogee Therapeutics, Inc.
ALKS / Alkermes plc
ALGS / Aligos Therapeutics, Inc.
TVTX / Travere Therapeutics, Inc.
NVCR / NovoCure Limited
DVAX / Dynavax Technologies Corporation
NVAX / Novavax, Inc.
AMAM / Ambrx Biopharma Inc.
ALLK / Allakos Inc.
SYRE / Spyre Therapeutics, Inc.
DYN / Dyne Therapeutics, Inc.
SRPT / Sarepta Therapeutics, Inc.
ACLX / Arcellx, Inc.
SLRN / Acelyrin, Inc.
TXG / 10x Genomics, Inc.
MRNA / Moderna, Inc.
NUVB / Nuvation Bio Inc.
IPSC / Century Therapeutics, Inc.
PACB / Pacific Biosciences of California, Inc.
BNTX / BioNTech SE - Depositary Receipt (Common Stock)
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
RLMD / Relmada Therapeutics, Inc.
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
ARGX / argenx SE - Depositary Receipt (Common Stock)
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
NUVL / Nuvalent, Inc.
PRTA / Prothena Corporation plc Put
ANAB / AnaptysBio, Inc.
EDIT / Editas Medicine, Inc.
GH / Guardant Health, Inc.
PTGX / Protagonist Therapeutics, Inc.
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
AGEN / Agenus Inc.
VIGL / Vigil Neuroscience, Inc.
TRML / Tourmaline Bio, Inc.
NTLA / Intellia Therapeutics, Inc.
CYTK / Cytokinetics, Incorporated Call
EWTX / Edgewise Therapeutics, Inc.
HRTX / Heron Therapeutics, Inc.
NBIX / Neurocrine Biosciences, Inc.
PRTA / Prothena Corporation plc Call
ITCI / Intra-Cellular Therapies, Inc.
HLVX / HilleVax, Inc.
FDMT / 4D Molecular Therapeutics, Inc.
OLMA / Olema Pharmaceuticals, Inc.
VRDN / Viridian Therapeutics, Inc.
SWTX / SpringWorks Therapeutics, Inc.